Newton, MA, United States of America

Anna I Mandinova

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 2.9

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2012-2023

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Anna I Mandinova

Introduction

Anna I Mandinova is an accomplished inventor based in Newton, MA, USA. With a remarkable portfolio of 10 patents, she has made significant contributions to the field of biomedical technologies, specifically in the areas related to innovative delivery methods and treatments. Her research focuses on developing novel applications that aim to enhance medical treatment and patient outcomes.

Latest Patents

Among her latest inventions is a patent for a "Systemic delivery of polypeptides." This groundbreaking method enables the systemic delivery of therapeutic polypeptides by creating genetically modified skin cells. Through the topical introduction of a genetically engineered virus that delivers a nucleic acid encoding the polypeptide, skin cells can express and secrete therapeutic agents directly into the subject's circulatory system.

Another noteworthy patent is for "Agents and methods for treating and preventing seborrheic keratosis." This patent outlines methods for isolating and culturing seborrheic keratosis cells ex vivo. It also provides comprehensive screening assays using these cultured cells and innovative methods for treating seborrheic keratosis in patients, showcasing her dedication to advancing healthcare solutions.

Career Highlights

Anna has held pivotal positions in respected organizations such as The General Hospital Corporation and Canthera Therapeutics Inc. Her work with these institutions has allowed her to translate her innovative ideas into impactful medical applications, ultimately benefiting numerous patients.

Collaborations

Throughout her career, Anna has collaborated with esteemed colleagues, including Sam W. Lee and Victor A. Neel. These partnerships have fostered a dynamic exchange of ideas and knowledge, leading to groundbreaking advancements in her field.

Conclusion

Anna I Mandinova exemplifies the spirit of innovation and dedication as an inventor. Her contributions to the medical field, evidenced by her multiple patents and collaborative efforts, highlight the importance of continuing to push the boundaries of science and technology. Anna's work not only reflects her brilliance as an inventor but also her commitment to improving healthcare for future generations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…